Firy Inc. vs Illumina, Inc. — how do they compare? Firy Inc. trades at $12.03 (market cap $199.80M), while Illumina, Inc. trades at $278.93 (market cap $39.95B). The key difference: Illumina, Inc. is far larger — about 199.9× Firy Inc.'s market cap, and Firy Inc. is more actively traded (92,993 versus 3,169,503). Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and Illumina, Inc. for 83 Days on average.
| FIRY | ILMN | |
|---|---|---|
Market Cap | $199.80M | $39.95B |
Volume | 92,993 | 3,169,503 |
Sector | Technology | Health |
52-Week High | $13.10 | $293.69 |
52-Week Low | $2.28 | $91.00 |
Typical Hold Time | 13 Days | 83 Days |
Enterprise Value | $168.40M | $41.31B |
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $12.07, up 1.86% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $31.0 million but a net loss, continuing a trend of negative profitability. Recent developments include a major legal victory with a $719 million judgment and the appointment of Marc Lasry to the board, signaling strategic shifts under its new holding company structure.
The outlook remains challenged by persistent cash burn and negative margins, though the legal win offers potential upside. Risks include high cash outflow and competitive pressures. Analyst sentiment is mixed with a hold-dominated consensus, reflecting uncertainty around the company's path to profitability.
Illumina (ILMN) trades at $278.17, up 3.89% today and near its 52-week high of $278.99. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent inclusion in the S&P 500 and positive analyst upgrades reflect growing institutional confidence. Revenue remains stable at $4.34B for 2025 with improved profitability, delivering $850M net income after previous losses.
The outlook remains positive with sequencing growth and AI initiatives driving momentum, though elevated valuation ratios and China market headwinds present risks. Analyst consensus leans bullish with 54% buy ratings, but the current price exceeds the $241 consensus target, suggesting near-term consolidation potential before further upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →